Edesa Biotech, Inc. Stock News

TORONTO, ON / ACCESSWIRE / July 30, 2020 / Edesa Biotech, Inc.

TORONTO, ON / ACCESSWIRE / June 15, 2020 / Edesa Biotech, Inc. (EDSA), a clinical-stage biopharmaceutical company, has received expedited approval from Health Canada to begin a Phase 2/3 clinical stud

By David Bautz, PhD NASDAQ:EDSA READ THE FULL EDSA RESEARCH REPORT Business Update Update on Phase 2b Trial of EB01 Edesa Biotech, Inc. (NASDAQ:EDSA) is currently conducting a Phase 2b clinical trial

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although Amazon.com...

TORONTO, ON / ACCESSWIRE / May 15, 2020 / Edesa Biotech, Inc. (NASDAQ:EDSA), a clinical-stage biopharmaceutical company, today reported financial results for the three and six months ended March 31, 2

By David Bautz, PhD NASDAQ:EDSA READ THE FULL EDSA RESEARCH REPORT Business Update Licenses Two Assets for Potentially Treating COVID-19 On April 20, 2020, Edesa Biotech, Inc. (NASDAQ:EDSA) announced

Gainers World Wrestling Entertainment (NYSE: WWE) shares are trading higher after the company reported better-than-expected Q1 EPS and sales results. Edwards Lifesciences (NYSE:...

TORONTO, ON / ACCESSWIRE / April 20, 2020 / Edesa Biotech, Inc. (EDSA), a clinical-stage biopharmaceutical company, today announced a strategic agreement with Light Chain Bioscience (a brand of NovImm

Edesa Biotech (NASDAQ:EDSA) and Stemline Therapeutics (NASDAQ:STML) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of

By David Bautz, PhD NASDAQ:EDSA READ THE FULL EDSA RESEARCH REPORT We are initiating coverage of Edesa Biotech, Inc. (NASDAQ:EDSA) with a valuation of $5.00. Edesa is a biopharmaceutical company focus

TORONTO, ON / ACCESSWIRE / March 12, 2020 / Edesa Biotech, Inc. (EDSA), a clinical-stage biopharmaceutical company, today announced a collaborative research project with the National Research Council

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Feb. 27) Global Cord Blood Corp (NYSE: CO ) Cleveland BioLa

TORONTO, ON / ACCESSWIRE / February 13, 2020 / Edesa Biotech, Inc. (NASDAQ:EDSA), a clinical-stage biopharmaceutical company, today reported financial results for the three months ended December 31, 2

Tables of the top insider purchases and sales filed with the SEC on 1/10/20, based on dollar value. Dollar values often do not equate with significance when it

TORONTO, ON / ACCESSWIRE / January 6, 2020 / Edesa Biotech, Inc. (EDSA), a clinical-stage biopharmaceutical company, today announced that it has entered into definitive securities purchase agreements